Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Statement of Comprehensive Income

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Allergan Inc., consolidated statement of comprehensive income

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Net earnings
Foreign currency translation adjustments
Reclassification adjustment for foreign currency translation gains included in net earnings from the substantially complete liquidation of an investment in a foreign subsidiary
Unrealized holding gain on available-for-sale securities, net of tax
Amortization of deferred holding gains on derivatives designated as cash flow hedges included in net earnings, net of tax
Net gain (loss), net of tax
Net gain on remeasurement of postretirement benefit plan liability, net of tax
Additional net prior service cost due to plan amendments, net of tax
Amortization, net of tax
Pension and postretirement benefit plan adjustments
Other comprehensive income (loss), net of tax
Comprehensive income (loss)
Comprehensive income attributable to noncontrolling interest
Comprehensive income (loss) attributable to Allergan, Inc.

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

Comprehensive income item Description The company
Net earnings attributable to Allergan, Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Allergan Inc. net earnings attributable to Allergan, Inc. decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.
Comprehensive income (loss) attributable to Allergan, Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Allergan Inc. comprehensive income (loss) attributable to Allergan, Inc. decreased from 2012 to 2013 but then increased from 2013 to 2014 exceeding 2012 level.